| 1 |
32815004 | In vitro assessment of the photo(geno)toxicity associated with Lapatinib, a Tyrosine Kinase inhibitor. | 2021 Jan |
2 |
| 2 |
33005299 | Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report. | 2020 Sep 15 |
1 |
| 3 |
29950679 | Biomarker discovery by integrated joint non-negative matrix factorization and pathway signature analyses. | 2018 Jun 27 |
1 |
| 4 |
28423638 | HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E. | 2017 Mar 21 |
1 |
| 5 |
26673621 | Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas. | 2016 Jan 19 |
1 |
| 6 |
26405815 | Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma. | 2015 |
1 |
| 7 |
24628946 | Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. | 2014 Jul |
1 |
| 8 |
23365119 | Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas. | 2013 May |
1 |